Summary
- Current Price
- As of today, RARE price is $16.63, up +2.02% on
- Current Price All-Time High
- RARE price is currently -90.74% below its historical high of $179.65 set on
- Market Cap
- RARE current market cap is $2B, down -49.12% year-over-year
- Revenue
- RARE current annual revenue is $673.00M, up +20.13% year-over-year
- Next Earnings
- As of today, the next earnings release for RARE has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Ultragenyx Pharmaceutical Inc. |
| Ticker | NASDAQ: RARE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | ultragenyx.com |
| Employees | 1,294 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $16.63 | |
| Price, 1D Change | +2.02% | |
| $2B | ||
| - | ||
| - | ||
| 1.31 | ||
| $673.00M | ||
| Revenue, 1Y Change | +20.13% | |
| -$5.83 | ||
| EPS, 1Y Change | +7.24% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$5.83 | ||
| EPS Estimate | -$4.08 | N/A |
| EPS Est. Change | +30.08% | N/A |
| $673.00M | ||
| Revenue Estimate | $760.21M | N/A |
| Revenue Est. Change | +12.96% | N/A |
| Current Price | $16.63 | |
| Price Target | $24.00 | - |
| Price Tgt. Change | +44.32% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$6.17 | -$6.29 | -1.97% | |
| -$5.64 | -$5.83 | -3.46% | |
| -$4.08 | N/A | +30.08% | |
| $0.23 | N/A | +103.87% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $554.66M | $560.23M | +1.00% | |
| $668.09M | $673.00M | +0.73% | |
| $760.21M | N/A | +12.96% | |
| $997.05M | N/A | +48.15% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $16.63 | |
| $22.83 | ||
| $16.64 | ||
| $23.08 | ||
| $17.47 | ||
| $0.05 | ||
| 1.31 | ||
| $0.83 | ||
| 53.98 | ||
| 41.82% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $673.00M | ||
| -$5.83 | ||
| $564.00M | ||
| 79.79% | ||
| -$535.00M | ||
| -79.49% | ||
| -$575.00M | ||
| -85.44% | ||
| -$500.00M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 2.48 | ||
| 2.34 | ||
| - | ||
| 2 | ||
| -3.80 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 2.29 | ||
| -5.63 | ||
| -5.13 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$80.00M | ||
| $737.00M | ||
| $1.53B | ||
| $951.00M | ||
| $1.61B | ||
| $384.00M | ||
| $1.25B | ||
| $81.00M | ||
| $31.00M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.25B | ||
| $1.10B | ||
| $136.00M | ||
| $0.00 | ||
| $35.00M | ||
| $0.00 | ||
| $4.00M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$466.00M | ||
| $236.00M | ||
| $478.00M | ||
| $21.00M | ||
| -$487.00M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| UBS | ||
| Evercore ISI Group | → | |
| Barclays | → | |
| Morgan Stanley | → | |
| Citigroup | → | |
| Cantor Fitzgerald | → | |
| Canaccord Genuity | → | |
| Citigroup | → | |
| Goldman Sachs | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
No data
Screeners with RARE
FAQ
- What is the ticker symbol for Ultragenyx Pharmaceutical Inc.?
- The ticker symbol for Ultragenyx Pharmaceutical Inc. is NASDAQ:RARE
- Does Ultragenyx Pharmaceutical Inc. pay dividends?
- No, Ultragenyx Pharmaceutical Inc. does not pay dividends
- What sector is Ultragenyx Pharmaceutical Inc. in?
- Ultragenyx Pharmaceutical Inc. is in the Healthcare sector
- What industry is Ultragenyx Pharmaceutical Inc. in?
- Ultragenyx Pharmaceutical Inc. is in the Biotechnology industry
- What country is Ultragenyx Pharmaceutical Inc. based in?
- Ultragenyx Pharmaceutical Inc. is headquartered in United States
- When did Ultragenyx Pharmaceutical Inc. go public?
- Ultragenyx Pharmaceutical Inc. initial public offering (IPO) was on January 31, 2014
- Is Ultragenyx Pharmaceutical Inc. in the S&P 500?
- No, Ultragenyx Pharmaceutical Inc. is not included in the S&P 500 index
- Is Ultragenyx Pharmaceutical Inc. in the NASDAQ 100?
- No, Ultragenyx Pharmaceutical Inc. is not included in the NASDAQ 100 index
- Is Ultragenyx Pharmaceutical Inc. in the Dow Jones?
- No, Ultragenyx Pharmaceutical Inc. is not included in the Dow Jones index
- When was Ultragenyx Pharmaceutical Inc. last earnings report?
- Ultragenyx Pharmaceutical Inc.'s most recent earnings report was on November 3, 2026
- When does Ultragenyx Pharmaceutical Inc. report earnings?
- The date for Ultragenyx Pharmaceutical Inc.'s next earnings report has not been announced yet
Data Sources & References
- RARE Official Website www.ultragenyx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1515673/000119312526057329/0001193125-26-057329-index.htm
- RARE Profile on Yahoo Finance finance.yahoo.com/quote/RARE
- RARE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rare